Epirubicin and vinorelbine versus single agent epirubicin as first line chemotherapy in metastatic breast cancer

被引:2
|
作者
Ejlertsen, B [1 ]
Mouridsen, H [1 ]
Langkjer, ST [1 ]
Andersen, J [1 ]
Sjostrom, J [1 ]
Kjaer, M [1 ]
机构
[1] Rigshosp, Finsen Ctr, DK-2100 Copenhagen, Denmark
关键词
D O I
10.1016/S0959-8049(02)80197-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
111
引用
收藏
页码:S66 / S67
页数:2
相关论文
共 50 条
  • [1] Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients
    Michelotti, A
    Venturini, M
    Tibaldi, C
    Bengala, C
    Gallo, L
    Carnino, F
    Del Mastro, L
    Lionetto, R
    Montanaro, E
    Rosso, R
    Conte, P
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2000, 59 (02) : 133 - 139
  • [2] Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients
    Andrea Michelotti
    Marco Venturini
    Carmelo Tibaldi
    Carmelo Bengala
    Luigi Gallo
    Flavio Carnino
    Lucia Del Mastro
    Rita Lionetto
    Elda Montanaro
    Riccardo Rosso
    Pierfranco Conte
    [J]. Breast Cancer Research and Treatment, 2000, 59 : 133 - 139
  • [3] Epirubicin/vinorelbine as first line therapy in metastatic breast cancer
    Baldini, E
    Tibaldi, C
    Chiavacci, F
    Di Lieto, M
    Fioretto, L
    Giallombardo, A
    Taviani, R
    Ghezzi, P
    Bolognini, A
    Conte, P
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (02) : 129 - 134
  • [4] Epirubicin/vinorelbine as first line therapy in metastatic breast cancer
    Editta Baldini
    Carmelo Tibaldi
    Franco Chiavacci
    Marco Di Lieto
    Luisa Fioretto
    Annalia Giallombardo
    Roberto Taviani
    Paolo Ghezzi
    Anna Bolognini
    Pierfranco Conte
    [J]. Breast Cancer Research and Treatment, 1998, 49 : 129 - 134
  • [5] First-line treatment with epirubicin and vinorelbine in metastatic breast cancer
    Vici, P
    Colucci, G
    Gebbia, V
    Amodio, A
    Giotta, F
    Belli, F
    Conti, F
    Gebbia, N
    Pezzella, G
    Valerio, MR
    Brandi, M
    Pisconti, S
    Durini, E
    Giannarelli, D
    Lopez, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) : 2689 - 2694
  • [6] Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
    Huang, Liang
    Wang, Xiaojia
    Zhou, Liheng
    Di, Lijun
    Zheng, Hongyu
    Jiang, Zefei
    Wang, Yongsheng
    Song, Xiangqun
    Feng, Jifeng
    Yu, Shiying
    Liu, Yunpeng
    Zheng, Hong
    Shen, Kunwei
    Tong, Zhongsheng
    Shao, Zhimin
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (01) : 205 - 215
  • [7] Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
    Liang Huang
    Xiaojia Wang
    Liheng Zhou
    Lijun Di
    Hongyu Zheng
    Zefei Jiang
    Yongsheng Wang
    Xiangqun Song
    Jifeng Feng
    Shiying Yu
    Yunpeng Liu
    Hong Zheng
    Kunwei Shen
    Zhongsheng Tong
    Zhimin Shao
    [J]. Cancer Chemotherapy and Pharmacology, 2020, 85 : 205 - 215
  • [8] Phase III study of vinorelbine plus epirubicin versus epirubicin alone in first-line chemotherapy of metastatic breast cancer:: An Scandinavian breast group study (SBG9403)
    Ejlertsen, B
    Mouridsen, HT
    Langkjer, ST
    Andersen, J
    Sjöström, J
    Kjaer, M
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 : S19 - S19
  • [9] WEEKLY EPIRUBICIN AND DOCETAXEL AS FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER
    D'Ottavio, A.
    Vaccaro, A.
    Belli, F.
    Nunziata, C.
    Meliffi, L.
    Moscetti, L.
    Barduagni, M.
    Sperduti, I.
    Gamucci, T.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 19 - 19
  • [10] Mitomycin (M), epirubicin (E) and vinorelbine (V) first-line chemotherapy for metastatic breast cancer (MBC). A feasibility study
    Neri, A
    Guarnieri, A
    Tucci, E
    Pepi, F
    Mazzocchi, B
    Algeri, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S44 - S44